Found 0 matching trials
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD PHASE4 This phase 4 study will explore, in the context of the present French clini...
Show More Location
Coordinating center (Hôpital de La Timone) and 18 associated centers in France
Learn More & Join Trial
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene PHASE1 This phase Ib/II trial tests the safety, side effects, best dose and how we...
Show More Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias N/A Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause ...
Show More Location
University of California Los Angeles
Learn More & Join Trial
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars N/A This comparative effectiveness and descriptive retrospective cohort study w...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma PHASE3 This randomized phase III trial compares two different high-dose chemothera...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer PHASE1 RATIONALE: Pentostatin may stop the growth of cancer cells by blocking some...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia PHASE1 This phase I trial tests the safety, side effects, and best dose of FH-FOLR...
Show More Location
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Learn More & Join Trial
PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE2 This phase II trial studies the side effects of PD 0360324 and cyclophospha...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease EARLY_PHASE1 This early phase I trial tests the safety, side effects and how well medica...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis N/A The aim of this research is to understand how lipids such as cholesterol af...
Show More Location
University College London Hospitals NHS Foundation Trust
Learn More & Join Trial